1. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry;Clewell;Crit. Rev. Toxicol.,2002
2. Kidney stone disease;Coe;J. Clin. Invest.,2005
3. Evolution of science-based uncertainty factors in noncancer risk assessment;Dourson;Regul. Toxicol. Pharmacol.,1996
4. EPA, 2005. Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001F. Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=116283).
5. EPA, 2006. A Framework for Assessing Health Risks of Environmental Exposures to Children, EPA/600/R-05/093F. Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=158363.